Clinical Trial Update: Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer [NA]

View source ↗

Summary

ClinicalTrials.gov entry describing a trial comparing proton therapy versus IMRT for low- or intermediate-risk prostate cancer. The study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING